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para-aortic splanchnopleura before the onset of circula-
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Summary the aorta±gonad±mesonephros (AGM) region of the 10.5
dpc embryo has been shown to harbor spleen colony-
The origin of hematopoietic stem cells (HSCs) and their forming units (CFU-S) and long-term repopulating HSCs
growth factor requirement are poorly understood. Here (LTR-HSCs) (Medvinsky et al., 1993; MuÈ ller et al., 1994;
we describe a new in vitro culture system of the aorta± Medvinsky and Dzierzak, 1996). Based on the reconsti-
gonad±mesonephros (AGM) region, where long-term tution experiments using irradiated mice, it was demon-
repopulating HSCs first arise. We demonstrate that strated that LTR-HSCs are not present in the yolk sac
oncostatin M (OSM) is expressed in the AGM and is before circulation and first appear in the AGM region
absolutely required for the expansion of multipotential followed by amplification in the fetal liver. In contrast,
hematopoietic progenitors in vitro. In addition, OSM very recent studies have shown that the yolk sac HSCs
enhances the formation of endothelial cell clusters. at 9.0 and 10.0 dpc can contribute to definitive hemato-
Thus, OSM appears to be a key cytokine for the devel- poiesis when conditioned newborn mice instead of irra-
opment of multipotential hematopoietic progenitors in diated adult mice are used as recipients for hematopoi-
the AGM, possibly acting on common precursor cells etic transplantation (Yoder and Hiatt, 1997; Yoder et al.,
between HSCs and endothelial cells. Byusing the AGM 1997a, 1997b). The nature of HSCs from both sites needs
culture derived from macrophage colony-stimulating to be furthercharacterized to reconcile this discrepancy.
factor (M-CSF)±deficient op/op mutant embryos, we LTR-HSCs in the AGM region and fetal liver are known
also show a pivotal role for M-CSF in fetal myelo- to be c-Kit1, CD341 (Sanchez et al., 1996), whereas adult
poiesis. LTR-HSCs in bone marrow have been shown to be Lin2,
c-Kit1, Sca-11, CD342 (Osawa et al., 1996). While Mac-1
expression is a maker of differentiated myeloid cells inIntroduction
the adult hematopoietic cells, some LTR-HSCs in the
AGM and fetal liver have been shown to express Mac-1During mouse embryogenesis, hematopoiesis begins in
(Morrison et al., 1995; Sanchez et al., 1996). Thus, local-embryos at approximately 7.5 days postcoitum (dpc) in
ization and developmental stage are the critical factorsthe yolk sac as blood islands, then shifts to the fetal
for the phenotypes of HSCs. Since the cytokine require-liver after 11.5 dpc and later to spleen and bone marrow
ments of various lineages of hematopoietic cells in the(Moore and Metcalf, 1970; Johnson and Moore, 1975;
adult bone marrow have been extensively studied in thereviewed by Dzierzak and Medvinsky, 1995). Hemato-
past decade, it is possible to amplify lineage-committedpoiesis prior to the formation of the fetal liver is known
hematopoietic progenitors in vitro in the presence ofas primitive hematopoiesis and is distinguished from
appropriate cytokines and stromal cells. However, the
molecular mechanism of the initiation of hematopoiesis
and growth factor requirement of LTR-HSCs in the AGM‖ To whom correspondence should be addressed (e-mail: miyajima
@ims.u-tokyo.ac.jp). remain to be elucidated. To address these questions,
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we have developed a novel in vitro cell culture system
using oncostatin M (OSM), which efficiently supports
the expansion of hematopoietic progenitor cells in the
AGM region.
OSM is a member of the interleukin-6 (IL-6) family of
cytokines that use gp130 as a common signal trans-
ducer. Among the family members, leukemia inhibitory
factor (LIF) and OSM are the most closely related func-
tionally, structurally, and genetically (Rose and Bruce,
1991; Bruce et al., 1992; Jeffery et al., 1993; Rose et al.,
1994). In fact, human OSM (hOSM) and LIF share the
same receptor, consisting of gp130 and the LIF receptor
b chain (LIFRb) (Gearing et al., 1992; Thoma et al., 1994).
The same receptor is also used by ciliary neurotrophic
factor (Davis et al., 1993) and cardiotrophin-1 (Pennica
et al., 1995). In addition, hOSM has a second functional
receptor that is composed of gp130 and the OSM recep-
tor b chain (OSMRb) (Mosley et al., 1996). Curiously,
mouse OSM (mOSM) had not been identified until we
recently cloned the mOSM cDNA as a cytokine-inducible
early response gene in hematopoietic cells (Yoshimura
et al., 1996). OSM expression is induced by cytokines
such as IL-3 and erythropoietin (EPO) through theactiva-
tion of the Jak/STAT5 (Janus kinase/signal transducer
and activator of transcription-5) signaling pathway (Mui
et al., 1996; Yoshimura et al., 1996).
We have previously found that mOSM is most abun-
dantly expressed in bone marrow cells, but mOSM alone
or in combination with other cytokines, such as IL-3,
IL-6, stem cell factor (SCF), and EPO, did not stimulate
or enhance the colony formation of the bone marrow
cells (Y. M. et al., unpublished data). However, recent
reports have implicated the IL-6/LIF cytokine family in
the development of hematopoietic progenitor cells: im-
paired hematopoiesis in gp130 knockout mice (Yoshida
et al., 1996); in vitro expansion of human cord blood
CD341 hematopoietic progenitors by a combination of
IL-6, soluble IL-6 receptor a chain (sIL-6Ra), and SCF
(Sui et al., 1995); and the increase of hematopoietic
progenitors in IL-6/sIL-6Ra double-transgenic mice (Pe-
ters et al., 1997).
Since gene targeting of IL-6 (Kopf et al., 1994),LIF (Stew-
art et al., 1992; Escary et al., 1993) and ciliary neuro-
trophic factor (Masu et al., 1993) results in normal hema- Figure 1. Expression of mOSM in the AGM and Gonadal Regions
topoiesis, we investigated a possible role for OSM in (A) RT-PCR analysis of mOSM or HPRT mRNA isolated at 11.5 dpc
hematopoiesis initiated in the AGM region of mouse from the AGM regions and at 13.5 dpc from the gonads. The PCR
embryos. In this report, we demonstrate that OSM is products were separated on an agarose gel, stained with ethidium
bromide, andphotographed. Identity of the PCRband as mOSM wasexpressed in the AGM region and that OSM in combina-
confirmed by hybridization with a digoxigenin±end-labeled internaltion with SCF and basic fibroblast growth factor (bFGF)
oligonucleotide. (B and C) In situ hybridization of mOSM mRNA instimulates the development of multipotential hemato-
the transverse section of the AGM region at 11.5 dpc. Frozen sec-
poietic progenitors and various lineages of hematopoi- tions were hybridized with the digoxigenin-labeled antisense mOSM
etic cells in the in vitro AGM culture system, suggesting cRNA probe (B) or sense control probe (C). Arrowheads, periphery
that OSM is a critical cytokine for the initiation of defini- of the genital ridge; arrow, spinal cord.
tive hematopoiesis in mouse embryos.
12.5±13.5 dpc of both males and females (Figure 1A).
We further analyzed the expression of OSM mRNA inResults
the embryo at 11.5 dpc by in situ hybridization. The
anti-sense OSM cRNA probe specifically bound to theOSM Is Expressed in the AGM and Gonadal Region
Expression of OSM was detected by reverse tran- periphery of the genital ridge (Figure 1B, arrowheads)
and the spinal cord (arrow), but the sense cRNA probescriptase polymerase chain reaction (RT-PCR) in the
AGM region at 11.5 dpc as well as in the gonads at failed to hybridize these regions (Figures 1B and 1C),
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Figure 2. Development of Hematopoietic Cells from the AGM Regions In Vitro
Cells obtained at 11.5 dpc from the AGM region of C57BL/6 embryos were incubated for 3 days (A±D) and for 10 days (E±L) in the presence
of SCF and bFGF (A, E, and I); SCF, bFGF, and LIF (B, F, and J); SCF, bFGF, and mOSM (C, G, and K); or SCF, bFGF, LIF, and mOSM (D, H,
and L). Shown are phase-contrast microscopic views of the AGM-derived cells after in vitro culture. Original magnification, 403 (A±H) and
1003 (I±L).
indicating that OSM is expressed in the genital ridge at endothelial-like adherent cells (Figures 2C, 2G, and 2K).
The addition of both OSM and LIF did not further en-this stage.
hance the proliferation of either nonadherent cells or
endothelial-like adherent cells when compared to theProduction of Hematopoietic Cells by the
In Vitro AGM Culture System culture with OSM alone (Figures 2D, 2H, and 2L).
The round, nonadherent cells generated in the in vitroSince organ cultures of the para-aortic splanchnopleura
and AGM regions were used to demonstrate autono- AGM culture system were analyzed by May-GruÈ enwald-
Giemsa staining (Figures 3A±3D). Such cells generatedmous development of HSCs in these regions, cytokines
and specific environmental conditions must be neces- in the SF medium (Figure 3A) or the SF medium with LIF
(Figure 3B) mostly exhibited macrophage-like morphol-sary for the development of HSCs in these regions (Cu-
mano et al., 1996; Medvinsky and Dzierzak, 1996). To ogy with many vacuoles and granules in the cytoplasm.
In contrast, in the presence of OSM, not only did thedissect further the mechanism of the initiation of hema-
topoiesis, we attempted to establish an in vitro culture total number of hematopoietic cells increase, but also
small blastic cells with a large nucleus became a majorsystem of AGM-derived cells. The AGM region excised
from C57BL/6 mouse embryos at 11.5 dpc was trypsin- population (Figures 3C±3E).
The hematopoietic cells were further analyzed by flowized into single-cell suspension, and the cells were then
cultured in the presence of various combinations of cy- cytometry using monoclonal antibodies against various
cell surface markers. A major fraction (50%±70%) oftokines. In the basic culturemedium (SF), which contains
SCF and bFGF, adherent fibroblastic cells and few round the cells were Mac-11, Gr-11, Thy-1.21, Ter1191, c-Kit1
regardless of the presence or absence of mOSM (Figurenonadherent cells were observed after 3 and 10 days
of culture (Figures 2A, 2E, and 2I). The addition of LIF 4A). Weak expression of B220 was also detected. No
significant differences in the expression patterns ofto the basic SF medium did not change the cell morphol-
ogy or total numbers of round cells that appeared after these surface markers were observed between the cells
produced in the presence of OSM and those produced3 and 10 days of culture (Figures 2B, 2F, and 2J). In
contrast, the addition of OSM to the SF medium mark- in its absence. However, the cell population that was
c-Kit1, Sca-11, indicative of HSCs in adult bone marrow,edly enhanced the proliferation of the round nonadher-
ent hematopoietic cells after 10 days of culture (Figures significantly increased in the hematopoietic cells ex-
panded with OSM (Figure 4B).2G and 2K). In addition, OSM stimulated the growth of
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Figure 3. Phenotype of Nonadherent Cells in the In Vitro AGM Culture
(A±D) Cytospin samples of round nonadherent cells were stained with May-GruÈ enwald-Giemsa. Original magnification, 4003. (E) The numbers
of total nonadherent cells and morphologically blastic cells were counted and the percentage of blastic cells for each condition was determined.
Cytokines used to expand the cells: S, SCF; F, bFGF; L, LIF; and O, mOSM.
Expansion of Hematopoietic Progenitors 50% of the hematopoietic cells in the AGM culture sys-
tem were Mac-11 and Gr-11 cells (Figure 4A), thein the In Vitro AGM Culture by OSM
Colony-forming activity of the hematopoietic cells pro- Mac-12, Gr-12 population was separated by magnetic
beads and their colony-forming ability was examined.duced in the in vitro culture of the AGM region was
examined by methylcellulose culture in the presence The frequency of the cells forming a mixed colony in
the Mac-12, Gr-12 population was about 10-fold higherof IL-3, IL-6, and EPO (Table 1A). The total number of
colonies (CFU-C) as well as the numbers of granulocyte than that in the unfractionated cells (Table 1B), indicat-
ing that CFU-Mix is present in the Mac-12, Gr-12 popula-(CFU-G), macrophages (CFU-M), and granulocyte/mac-
rophages (CFU-GM) were markedly increased by the tion of the AGM-derived hematopoietic cells expanded
by OSM.addition of OSM during the AGM culture. Strikingly, the
mixed colony-forming cells (granulocyte, erythrocyte, Moreover, CFU-S of days 8 and 12, indicative of earlier
stages of hematopoietic progenitors, were detected onlymacrophage, and megakaryocyte [GEMM] or CFU-Mix)
were present only in the culture with OSM. These results in the cell population expanded in OSM-containing cul-
tures (Table 2); LIF cultures did not exhibit such activity.suggest that OSM stimulates the production of multipo-
tential hematopoietic progenitors. Since approximately Taken together, these results strongly suggest that OSM
Figure 4. Expression of the Lineage Markers
in Hematopoietic Cells Expanded In Vitro
from the AGM Region of C57BL/6 Mouse Em-
bryos
(A) Flow cytometric profiles of cells stained
with antibodies against Mac-1, Gr-1, B220,
Thy-1.2, and Ter119 (open histograms). Also
shown are the fluorescence profiles of cells
without primary antibodies (shaded histo-
grams).
(B) Double staining of cells with antibodies
against c-Kit and Sca-1. Cytokines used to
expand the cells: S, SCF; F, bFGF; L, LIF; and
O, mOSM.
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Table 1. CFU-C Activities in AGM-Derived Hematopoietic Cells in Culture
Number of Colonies per 104 cells
(A) Culture Conditions G M GM GEMM Total
SF 1.7 6 1.5 2.0 6 1.7 0 0 3.7 6 2.1
SFL 0 0.3 6 0.6 0.3 6 0.6 0 0.7 6 0.6
SFO 9.7 6 0.6 61.0 6 2.3 13.0 6 4.4 7.7 6 2.5 91.3 6 18.9
SFLO 9.7 6 4.6 71.7 6 13.3 21.3 6 6.7 8.7 6 3.1 111.3 6 11.6
Number of Colonies per 103 Mac-12, Gr-12 cells
(B) Culture Conditions G M GM GEMM Total
SF 0.3 6 0.6 0.7 6 0.6 1.0 6 1.0 0 2.0 6 1.0
SFL 0 0.7 6 0.6 0.3 6 0.6 0 1.0 6 1.0
SFO 12.0 6 2.0 44.0 6 6.9 10.7 6 5.8 5.7 6 2.9 72.3 6 11.6
SFLO 7.3 6 1.2 30.0 6 5.6 9.7 6 4.7 4.3 6 2.5 51.3 6 12.1
Hematopoietic cells expanded in the culture conditions indicated were inoculated in methylcellulose media containing IL-3, IL-6, and EPO.
Colonies were scored at 14 days after culture. The results represent the mean 6 SE of triplicate samples.
Colony types: G, granulocyte; M, macrophage; GM, granulocyte and macrophage; GEMM, granulocyte, erythrocyte, macrophage, and mega-
karyocyte. Culture conditions: S, SCF; F, bFGF; L, LIF; O, OSM.
stimulates the proliferation of multipotential hematopoi- clusters and hematopoietic cells in the in vitro AGM
culture.etic progenitors derived from the AGM region.
A Role for Macrophage Colony-StimulatingOSM Stimulates the Formation of Cobblestone
Factor in MyelopoiesisAreas and Endothelial-Like Clusters
While OSM increased the population of the hematopoi-During the course of the in vitro AGM culture, we noticed
etic cells with blastic morphology in the in vitro AGMthat OSM also enhanced the formation of endothelial-
culture (Figure 3), the majority of the hematopoietic cellslike cell clusters (Figures 2E±2L) as well as cells forming
produced in this culture system were still Mac-11, Gr-11cobblestone areas underneath the fibroblastic mono-
(Figure 4A). This observation is reminiscent of the find-layer (Figures 5A±5D). Formation of cobblestone area is
ing that major hematopoietic cells derived from embry-a unique feature of HSCs cocultured with stromal cells
onic stem (ES) cells cocultured with stromal cells were(Ploemacher et al., 1989), and it was absolutely depen-
macrophages. Of note, however, various lineages of he-dent on OSM in the AGM culture, suggesting that OSM
matopoietic cells were generated from the ES cellswhencould expand HSCs in the AGM region. We are currently
they were cocultured with the stromal cell line OP9 (Na-testing whether the HSCs generated by the in vitro AGM
kano et al., 1994, 1996) derived from the osteopetroticculture with OSM are able to repopulate all lineages of
op/op mouse, which lacks functional macrophage col-hematopoietic cells over the long term in lethally irradi-
ony-stimulating factor (M-CSF) (Yoshida et al., 1990;ated mice.
Kodama et al., 1994). This result indicates that M-CSFCells in the endothelial-like cluster incorporated
strongly induces the macrophage development andacetylated low-density lipoprotein labeled with DiI (1,19-
suppresses the differentiation of ES cells to other lin-dioctadecyl-3,3,39,39-tetramethylindo-carbocyanine per-
eages of blood cells.chlorate) (DiI-Ac-LDL) (Figures 5E and 5F), whose re-
To test whether M-CSF is responsible for the genera-ceptor is known to be expressed on macrophages and
tion of the Mac-11 population in the in vitro AGM cultureendothelial cells (Goldstein et al., 1979; Voyta et al.,
system, the AGM region of the M-CSF±deficient op/op1984). Furthermore, platelet endothelial cell adhesion
mutant embryos was cultured in the presence of SCF,
molecule-1 (PECAM-1) was expressed on the endothe-
bFGF, LIF, and OSM (Figures 6A±6C). Strikingly, most
lial-like cell clusters, as revealed by fluorescent immuno-
of the hematopoietic cells produced in the culture were
staining (data not shown). These results indicate that Mac-12, B2202, Thy-12, Ter-1192 (Figure 7). Weak ex-
the clusters are endothelial cells. We are currently ad- pression of Gr-1 was observed in some cells. Consistent
dressing the relationship between these endothelial cell with the lineage negative c-Kit1 phenotype, the cells
with blastic morphology dominated the hematopoietic
Table 2. CFU-S Activities in AGM-Derived Hematopoietic Cells cell population derived from the op/op AGM region (Fig-
in Culture ures 6D and 6E). CFU-GEMM (or CFU-Mix) and erythroid
Numberof Coloniesper 106 cells burst-forming units (BFU-E) were dramatically expanded
in the op/op AGM culture (Table 3). Moreover, the num-Culture Conditions Day 8 Day 12
bers as well as the size of cobblestone areas and the
SF 0 0 endothelial-like cell clusters were significantly increased
SFL 0.3 6 0.6 0 in the op/op AGM culture (Figures 6B and 6C). The
SFO 19.7 6 3.1 18.0 6 1.0
addition of M-CSF to the op/op AGM culture resultedSFLO 19.3 6 4.2 15.7 6 1.5
in a decrease in blastic cells as well as CFU-GEMM
The same hematopoietic cells as shown in Table 1 were injected and BFU-E (data not shown). These results collectively
into 60Co-irradiated C57BL/6 mice. Eight or 12 days after injection, suggest that M-CSF plays a critical role in myelopoiesis
colonies in spleen were counted.
at a very early stage.
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Figure 5. Phase-Contrast Microscopic View of Adherent Cells and DiI-Ac-LDL Uptake of Endothelial-Like Cell Cluster in the In Vitro AGM
Culture
(A±D) The adherent cells were grown in SF (A), SFL (B), SFO (C), and SFLO (D) media (S, SCF; F, bFGF; L, LIF; and O, mOSM). In the presence
of OSM, the dark round cells form a cobblestone area underneath the fibroblastic cell layer (C and D). Original magnification, 2003. (E and
F) Transmitted light±interference contrast microscopic view (E) and fluorescence-activated view (F) of adherent cells grown in SFLO medium
in the presence of DiI-AC-LDL. Original magnification, 1603.
Discussion progenitors from the 11.5 dpc AGM, as evidenced by
CFU-Mix, CFU-S, and formation of cobblestone areas.
The key element of this AGM culture togenerate multipo-We have established an in vitro culture system, amena-
ble to molecular analysis, of multipotential hematopoi- tential hematopoietic progenitors is OSM. Because ex-
pression of OSM was detected in the AGM region byetic progenitors derived from the AGM region. This cul-
ture system generates multipotential hematopoietic RT-PCR as well as in situ hybridization and because
Figure 6. Development of Hematopoietic Cells from the op/op Mutant AGM Regions In Vitro
Cells obtained from the AGM region of op/op embryos at 11.5 dpc were incubated for 10 days in the presence of SCF, bFGF, LIF, and mOSM.
(A±C) Morphology as viewed by phase-contrast microscopy of AGM-derived cells after in vitro culture. Original magnification, 403 (A) or 1003
(B and C). (D) Cytospin samples of round nonadherent cells were stained with May-GruÈ enwald-Giemsa. Original magnification, 4003. (E) The
numbers of total nonadherent cells and morphologically blastic cells in 1/1, op/1, and op/op AGM culture were counted and the percentage
of blastic cells for each culture was determined.
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OSM dramatically increased the total number of he-
matopoietic cells as well as the ratio of blastic cells in
the AGM culture. Although OSM did not significantly
change the expression of lineage markers, it did in-
crease the c-Kit1, Sca-11 population and blastic cell
population. Therefore, expression of surface makers
(such as Mac-1 and Gr-1) does not directly correlate
with differentiation potential as a progenitor in the AGM-
derived hematopoietic cells. Since c-Kit1 Sca-11 cells,
CFU-Mix, CFU-S, and cobblestone area±forming cells
accumulate during 10 days of culture with OSM, it is
reasonable to consider that multipotential hematopoi-
etic progenitors are generated in vitro from the AGM
region by this culture system. However, it remains to
be proven by long-term repopulation assays in lethallyFigure 7. Expression of the Lineage Markers in Hematopoietic Cells
Expanded In Vitro from the AGM Region of op/op Mutant Mouse irradiated mice whether this in vitro system expands
Embryos LTR-HSCs. This possibility is currently being examined.
Flow cytometric profiles of cells stained with antibodies against It is noteworthy that mOSM stimulated not only hemato-
Mac-1, Gr-1, B220, Thy-1.2, Ter119, and c-Kit (open histograms). poietic cells but also endothelial cell clusters (Figure 2G,
Also shown are the fluorescence profiles of cells without primary 2H, 2K, and 2L). This is an interesting finding because it
antibodies (shaded histograms).
is now believed that hematopoietic cells and endothelial
cells are derived from putative common precursors,
OSM isabsolutely required for the generation of multipo- hemangioblasts (Shalaby et al., 1995; Eichmann et al.,
tential hematopoietic progenitors in vitro, OSM may be 1997; reviewed by Risau, 1997). Because mOSM had no
a natural factor that stimulates hematopoiesis in the significant effect on the bone marrow cells (Y. M. et al.,
AGM region. Targetting of the OSM gene will provide unpublished data), it is possible that mOSM acts on the
more direct evidence as to whether OSM is required for precursors of HSCs in the AGM region and that the in
the initiation of hematopoiesis in the AGM region. vitro AGM culture we developed contains all the cellular
Although it is well established that OSM and LIF share components necessary for generating hemangioblasts,
many biological activities in the human, LIF failed to HSCs, and angioblasts in vitro. While this possibility has
stimulate hematopoiesis in the AGM region (Figures 2±5 yet to be proven, our culture system will be useful to
and Tables 1 and 2). The basis of the differential activity identify those presumptive precursor cells.
of LIF and OSM is most likely the receptor expression. Recent studies indicate a significant similarity in the
Human OSM is known to function through two distinct ontogeny of thegerm line and the hematopoieticsystem.
receptors: one is its own receptor, consisting of OSMRb Primordial germ cells (PGCs), which give rise to germ
and gp130, and the other is the LIF receptor, which cells, and yolk sac blood cells originate from the same
consists of LIFRb and gp130 (Mosley et al., 1996). How- region of epiblast in the day 6 extraembryonic meso-
ever, our recent studies on mouse OSM receptors indi- derm. At a later stage, not only definitive HSCs but also
cate that mOSM does not use the LIF receptor and that PGCs were identified in the AGM region of 10±11 dpc
hOSM activates the mLIF receptor but not the mOSM embryos. Furthermore, it was reported that primitive
receptor (Ichihara et al., 1997; Richards et al., 1997). hematopoietic cells can be derived directly from the 7.5
Thus, the functions of OSM and LIF are completely seg- and 8.5 dpc PGCs in vitro (Rich, 1995). While a small
regated in the mouse. It is therefore important to use number of alkaline phosphatase±positive PGCs were
mOSM, but not hOSM, in the AGM culture. The inability found in the 11.5 dpc AGM-derived cells at the initiation
of LIF to stimulate hematopoiesis in the AGM region is of the culture, no such cells were detectable after 4 days
most likely due to the lack of LIFRb. This is supported of culture (Y. M. and T. H., unpublished data). It cannot
by the finding that the addition of IL-6 and sIL-6Ra to the be formally excludedat present that PGCs become alka-
AGM culture enhanced the production of hematopoietic line phosphatase±negative cells with a potential to dif-
cells and increased the number of the endothelial-like ferentiate into hematopoietic cells. However, because
cell clusters in vitro from the AGM region in a manner OSM stimulates thedevelopment not only of hematopoi-
similar to mOSM (data not shown). Stimulation of these etic cells but also of endothelial cells, it is more likely
cells by mOSM and IL-6/sIL-6Ra was completely blocked that OSM stimulates hemangioblasts rather than PGCs
by anti-gp130 neutralizing antibodies (data not shown), in this culture system.
indicating that gp130 has a critical role in the prolifera- The in vitro AGM culture system is also useful to iden-
tion of AGM-derived hematopoietic progenitors. This is tify the growth or differentiation factors involved in he-
consistent with the hematopoietic defects in the gp130- matopoiesis by experimental manipulation, such as the
deficient embryos (Yoshida et al., 1996). Although it re- addition of a potential factor to the culture or blockage
mains unknown whether mOSM directly acts on the of a factor or receptor by neutralizing antibodies. The
HSCs themselves or their precursors in the AGM region, system is also applicable to the analysis of mutant mice
mOSMRb and gp130 but not LIFRb must be present on possessing hematopoietic defects, as exemplified by
such cells. Thus, the mOSM receptor may be an ideal the op/op mouse. The op/op mouse is defective in the
marker for isolating the hematopoietic precursors from production of M-CSF (Yoshida et al., 1990). The hemato-
poietic cells generated from the op/op AGM are for thethe AGM region.
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Table 3. CFU-C Activities in op/op AGM-Derived Hematopoietic Cells in SFLO Culture Condition
Number of Colonies per 104 cells
Genotype G M GM GEMM BFU-E Total
1/1 7.0 6 2.6 48.3 6 10.1 17.0 6 2.6 7.3 6 0.6 4.3 6 2.5 84.0 6 15.5
op/1 8.3 6 2.9 71.7 6 14.0 20.3 6 2.1 8.0 6 1.7 9.3 6 1.5 121.0 6 11.1
op/op 10.0 69.3 6 8.4 22.3 6 2.1 40.3 6 4.5 35.3 6 2.3 177.3 6 13.7
Hematopoietic cells expanded from AGM regions of 1/1, op/1, and op/op mice in the SFLO medium were inoculated in methylcellulose
media containing IL-3, IL-6, and EPO. Colonies were scored on day 14 of culture. The results represent the mean 6SE of triplicate samples.
Colony types: G, granulocyte; M, macrophage; GM, granulocyte and macrophage; GEMM, granulocyte, erythrocyte, macrophage, and mega-
karyocyte; BFU-E, erythroid burst-forming unit. Culture conditions: S, SCF; F, bFGF; L, LIF; O, OSM.
was transferred to a nylon membrane (Boehringer Mannheim), andmost part undifferentiated morphologically and pheno-
the filter was hybridized with a digoxigenin±end-labeled internaltypically, in marked contrast to cells in the AGM culture
oligonucleotide (59-ACAGAGTGCTGGGTGCAGGCA-39). Hybridiza-of the normal mouse embryos (Figure 6D), suggesting tion was performed at 378C, and the final wash condition was 63
that M-CSF plays a role in myelopoiesis. These results standard saline citrate/0.1% sodium dodecyl sulfate at 458C. The
are consistent with previous studies of in vitro hemato- hybridized blot was analyzed by the standard chemiluminescence
visualization procedure (Boehringer Mannheim) according to thepoiesis using ES cells (Borzillo et al., 1990). Whereas
manufacturer's instructions.most of the hematopoietic cells derived from ES cells
in the presence of stromal cells are macrophages, both
In Situ Hybridizationerythroid and B lymphoid lineages were efficiently gen-
Embryos at 11.5 dpc from C57BL/6 mice were directly fixed aterated from the same ES cells in the presence of the
48C in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.45)
OP9 stroma cell line (Nakano et al., 1994, 1996). Thus, overnight and then rinsed overnight in a series of sucrose solutions
M-CSF appears to becritically involved in the generation (10%±30%) in 50 mM phosphate buffer before being embedded in
of lineage-committed hematopoietic cells in vitro. It OCT compound (Miles, Elkhart, IN). Fifteen micron±thick sections
were cut with a cryostat and mounted on microscope slides coatedwould be useful to examine whether M-CSF is a commit-
with poly-L-lysine. The sections were dried immediately after mount-ment factor for the hematopoietic lineages absent in the
ing and kept at 2258C until use. Digoxigenin-labeled antisense andop/op AGM culture.
sense riboprobes were preparedby using the mOSMcDNA fragmentBecause the op/op mice are viable, an in vitro system
(nucleotide 211±507) in the pCRII vector (Invitrogen) and the RNA
may not be necessary to study the role of this gene. transcription kit (Stratagene) according to the manufacturers' in-
However, many genes are critically involved in hemato- structions. Hybridization was performed in a humid oven at 428C
for 18 hr, as previously described (Imakawa et al., 1995). Boundpoiesis, and mutations in these genes often result in
probes were visualized by using alkaline phosphatase±conjugatedembryonic lethality, making the functional analysis of
anti-digoxigenin antibody, and nitro blue tetrazolium and 5-bromo-those genes difficult. Because our in vitro system uses
4-chloro-3-indolyl-phosphate as substrates.
11.5 dpc embryos, hematopoiesis can be analyzed in
vitro if mice survive to 12 dpc and develop the AGM
In Vitro AGM Culture
region. Uncovering the molecular basis of the hemato- The AGM regions were excised at 11.5 dpc from C57BL/6 embryos
poietic defects in mutant mice defective in definitive or op/op mutant embryos and trypsinized as previously described
hematopoiesis will advance our understanding of hema- (Donovan et al., 1986). The cells were resuspended in Dulbecco's
modified Eagle's medium supplemented with 15% fetal calf serumtopoiesis during embryogenesis. In conclusion, the in
in the presence of various cytokines: 100 ng/ml SCF, 1 ng/ml bFGFvitro system we have developed will be useful for molec-
(Gibco±BRL), 10 ng/ml mLIF, and 10 ng/ml mOSM (from R&D Sys-ular dissection of the origin of hematopoiesis.
tems except as noted). After incubation at 378C and 5% CO2 for 10
days, cells were analyzed.
Experimental Procedures To evaluate IL-6±mediated biological response in this culture, the
cells were resuspended in the same medium as described above
Mice in the presence of 100 ng/ml IL-6 and 300 ng/ml sIL-6Ra (both from
Pregnant C57BL/6 mice were purchased from Nihon SLC. The op/ R&D Systems). For blocking experiments using anti-mouse gp130
op mice were obtained from breeder pairs of op/1 mice provided antibodies, a mixture of RX187 and RX435 (a gift from T. Taga,
by S. Hayashi (Tottori University, Tottori, Japan). Tokyo Medical and Dental University) at 5 mg/ml was added in this
culture.
RT-PCR and Southern Blot Analysis
RNA was extracted at 11.5±13.5 dpc from the AGM using the Quick
May-GruÈ enwald-Giemsa StainingPrep mRNA purification kit (Pharmacia) and was reverse-transcribed
Cells were centrifuged onto slides using a Cytospin (Shandon) atusing a first-strand cDNA synthesis kit (Pharmacia). The cDNAs were
800 rpm for 5 min. May-GruÈ enwald-Giemsa staining was performedamplified with Taq DNA polymerase (Takara, Tokyo) using a primer
as previously described (Nakahata and Ogawa, 1982).pair specific to mOSM (sense primer: 59-TCCGCCTCCAAAACCTGA
ACAC-39 and antisense primer: 59-ATGGTATCCCCAGAGAAAGC-
39) and to hypoxanthine phosphoribosyl transferase (HPRT) (sense Flow Cytometry
The monoclonal antibodies used in flow cytometry were anti-Mac-1primer: 59-CCTGCTGGATTACATTAAAGCACTG-39 and antisense
primer: 59-GTCAAGGGCATATCCAACAACAAAC-39) for 40 cycles (M1/70), anti-Gr-1 (RB6±8C5), anti-Thy-1.2 (30-H12), anti-B220
(RA3±6B2), anti-Ter-119 (Ter-119), anti-CD34 (RAM34), biotinylated(948C for 1 min, 558C for 2 min, and 728C for 3 min), respectively.
The sizes of the amplified PCR products are 382 bp (mOSM) and anti-c-Kit (3C1), fluorescein isothiocyanate (FITC)±conjugated anti-
Sca-1 (E13±161.7), and FITC-conjugated anti-PECAM-1 (MEC13.3),354 bp (HPRT). The products were separated on 1.5% agarose gel,
stained with ethidium bromide, and photographed. To confirm that which were purchased from Pharmingen.All antibodies except c-Kit,
Sca-1, and PECAM-1 were visualized by using FITC-conjugatedthe band generated by RT-PCR is specific for mOSM, the product
OSM Stimulates AGM Hematopoiesis In Vitro
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anti-rat immunoglobulin G (Pierce). The biotinylated anti-c-Kit anti- Ip, N.Y., and Yancopoulos, G.D. (1993). LIFR b and gp130 as hetero-
dimerizing signal transducers of the tripartite CNTF receptor. Sci-bodies were visualized by phycoerythrin-conjugated streptavidin
(Pharmingen). After cells were harvested from culture, they were ence 260, 1805±1808.
resuspended in phosphate-buffered saline and filtered through a Dieterlen-Lievre, F., and Martin, C. (1981). Diffuse intraembryonic
nylon mesh of 70 mm (Cell Strainer, FALCON) to remove cell debris. hemopoiesis in normal and chimeric avian development. Dev. Biol.
The cells were then incubated with monoclonal antibodies for 30 88, 180±191.
min on ice and analyzed by FACScan (Becton Dickinson). Donovan, P.J., Stott, D., Cairns, L.A., Heasman, J., and Wylie, C.C.
(1986). Migratory and postmigratory mouse primordial germ cells
CFU-C Assay behave differently in culture. Cell 44, 831±838.
Ten thousand hematopoietic cells or 1000 Mac-12, Gr-12 hemato-
Dzierzak, E., and Medvinsky, A. (1995). Mouse embryonic hemato-poietic cells were incubated in 1 ml of culture medium containing
poiesis. Trends Genet. 11, 356±366.
a-MEM, 0.8% methylcellulose, 30% fetal calf serum, 1% deionized
Eichmann, A., Corbel, C., Nataf, V., Vaigot, P., Breant, C., and Lebovine serum albumin, 100 mM 2-mercaptoethanol, 10 ng/ml IL-3,
Douarin, N.M. (1997). Ligand-dependent development of the endo-100 ng/ml IL-6, and 2 U/ml EPO. Purified IL-3 was prepared as
thelial and hemopoietic lineages from embryonic mesodermal cellspreviously described (Miyajima et al., 1987). IL-6 and EPO were
expressing vascular endothelial growth factor receptor 2. Proc.Natl.kindly provided by Ajinomoto and Kirin Brewery, respectively. Col-
Acad. Sci. USA 94, 5141±5146.ony types were determined on the 14th day of incubation as de-
scribed (Nakahata and Ogawa, 1982). Escary, J.-L., Perreau,J., Dumenil, D., Ezine, S., and Brulet, P. (1993).
Leukemia inhibitory factor is necessary for maintenance of hemato-
CFU-S Assay poietic stem cells and thymocyte stimulation. Nature 363, 361±364.
C57BL/6 recipient female mice at 8 weeks of age were irradiated Gearing, D.P., Comeau, M.R., Friend, D.J., Gimpel, S.D., Thut, C.J.,
(9.5 Gy) with a 60Co source and were injected intravenously with 106 McGourty, J., Brasher, K.K., King, J.A., Gills, S., Mosley, B., et al.
donor cells. On day 8 or 12 after injection, the number of colonies (1992). The IL-6 signal transducer, gp130: an Oncostatin M receptor
in the recipient spleen was counted. and affinity converter for the LIF receptor. Science 255, 1434±1437.
Godin, I.E., Garcia-Porrero, J.A., Coutinho, A., Dieterlen-Lievre, F.,
DiI-Ac-LDL Incorporation Assay and Marcos, M.A. (1993). Para-aortic splanchnopleura from early
Cells from the AGM region were cultured on four-well chamber- mouse embryos contains B1a cell progenitors. Nature 364, 67±70.
slide (Nalge Nunc International). After 8 days of culture, the cells
Goldstein, J.L.,Ho, Y.K., Basu, S.K., andBrown, M.S. (1979). Bindingwere incubated with DiI-Ac-LDL (10 mg/ml, Biomedical Technolo-
site on macrophages that mediatesuptake and degradation of acet-gies) for 4 hr at 378C and then fixed in 4% paraformaldehyde/PBS
ylated low density lipoprotein, producing massive cholesterol depo-for 20 min at room temperature and analyzed by confocal micros-
sition. Proc. Natl. Acad. Sci. USA 76, 333±337.copy fitted with the necessary filters to detect the emitted fluores-
Ichihara, M., Hara, T., Kim, H., Murate, T., and Miyajima, A. (1997).cence.
Oncostatin M and leukemia inhibitory factor do not utilize the same
functional receptor in mice. Blood 90, 165±173.Acknowledgments
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